Literature DB >> 19519227

Rapid development of advanced liver fibrosis after acquisition of hepatitis C infection during primary HIV infection.

Anu Osinusi1, David Kleiner, Brad Wood, Michael Polis, Henry Masur, Shyam Kottilil.   

Abstract

We report the first reported case of a 61-year-old MSM who was diagnosed with syphilis, primary HIV infection, and acute hepatitis C (HCV) within the same time period who rapidly developed significant liver fibrosis within 6 months of acquisition of both infections. It has been well described that individuals with primary HIV infection have an increase in activated CD8+ T cells, which causes a state of immune activation as was evident in this patient. Acquisition of HCV during this time could have further skewed this response resulting in massive hepatocyte destruction, inflammation, and subsequent liver fibrosis. Recent literature suggest that MSM with primary HIV infection have higher rates of acquisition of HCV than other HIV-positive cohorts and HCV acquisition can occur very soon after acquiring HIV. This case of rapid hepatic fibrosis progression coupled with the increasing incidence of HCV in individuals with primary HIV infection demonstrates a need for this phenomenon to be studied more extensively.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19519227      PMCID: PMC2879494          DOI: 10.1089/apc.2008.0238

Source DB:  PubMed          Journal:  AIDS Patient Care STDS        ISSN: 1087-2914            Impact factor:   5.078


  13 in total

1.  Risk factors for fibrosis progression in HIV/HCV coinfected patients from a retrospective analysis of liver biopsies in 1985-2002.

Authors:  M Schiavini; E Angeli; A Mainini; P Zerbi; P G Duca; G Gubertini; L Vago; P Fociani; R Giorgi; A Cargnel
Journal:  HIV Med       Date:  2006-07       Impact factor: 3.180

2.  Host genetic factors influence disease progression in chronic hepatitis C.

Authors:  E E Powell; C J Edwards-Smith; J L Hay; A D Clouston; D H Crawford; C Shorthouse; D M Purdie; J R Jonsson
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

3.  Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.

Authors:  Matilde Sánchez-Conde; Juan Berenguer; Pilar Miralles; Federico Alvarez; Juan Carlos Lopez; Jaime Cosin; Catalán Pilar; Margarita Ramirez; Isabel Gutierrez; Emilio Alvarez
Journal:  Clin Infect Dis       Date:  2006-07-27       Impact factor: 9.079

4.  Does HIV infection favor the sexual transmission of hepatitis C?

Authors:  P Filippini; N Coppola; C Scolastico; G Rossi; M Onofrio; E Sagnelli; F Piccinino
Journal:  Sex Transm Dis       Date:  2001-12       Impact factor: 2.830

5.  Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.

Authors:  Y Benhamou; M Bochet; V Di Martino; F Charlotte; F Azria; A Coutellier; M Vidaud; F Bricaire; P Opolon; C Katlama; T Poynard
Journal:  Hepatology       Date:  1999-10       Impact factor: 17.425

6.  Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.

Authors:  Luz Martín-Carbonero; Yves Benhamou; Massimo Puoti; Juan Berenguer; José Mallolas; Carmen Quereda; Ana Arizcorreta; Antonio Gonzalez; Jurgen Rockstroh; Victor Asensi; Pilar Miralles; Montse Laguno; Leonor Moreno; José Antonio Girón; Martin Vogel; Javier García-Samaniego; Marina Nuñez; Miriam Romero; Santiago Moreno; Juan José de la Cruz; Vincent Soriano
Journal:  Clin Infect Dis       Date:  2003-12-08       Impact factor: 9.079

7.  Progression of fibrosis in chronic hepatitis C.

Authors:  Marc G Ghany; David E Kleiner; Harvey Alter; Edward Doo; Farooq Khokar; Kittichai Promrat; David Herion; Yoon Park; T Jake Liang; Jay H Hoofnagle
Journal:  Gastroenterology       Date:  2003-01       Impact factor: 22.682

8.  Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.

Authors:  Carmen Martinez-Sierra; Ana Arizcorreta; Fernando Díaz; Rafael Roldán; Leopoldo Martín-Herrera; Eugenio Pérez-Guzmán; José A Girón-González
Journal:  Clin Infect Dis       Date:  2003-01-31       Impact factor: 9.079

9.  Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome.

Authors:  A Cossarizza; C Ortolani; C Mussini; V Borghi; G Guaraldi; N Mongiardo; E Bellesia; M G Franceschini; B De Rienzo; C Franceschi
Journal:  J Infect Dis       Date:  1995-07       Impact factor: 5.226

10.  Incidence and predictors of severe liver fibrosis in HIV-infected patients with chronic hepatitis C in Brazil.

Authors:  Maria Cássia Mendes-Correa; Azzo Widman; Maria Luiza Paes Brussi; Cristina Fátima Guastini; Reinaldo José Gianini
Journal:  AIDS Patient Care STDS       Date:  2008-09       Impact factor: 5.078

View more
  3 in total

1.  Epidemic of Sexually Transmitted Hepatitis C Virus Infection Among HIV-Infected Men.

Authors:  Daniel Seth Fierer
Journal:  Curr Infect Dis Rep       Date:  2010-03       Impact factor: 3.725

2.  Experiences of Oxford House Residents Living with the Hepatitis C Virus.

Authors:  Richard Contreras; Leonard A Jason
Journal:  Front Psychol Behav Sci       Date:  2013-04-01

3.  Social determinants of health associated with hepatitis C co-infection among people living with HIV: results from the Positive Spaces, Healthy Places study.

Authors:  Sean B Rourke; Michael Sobota; Ruthann Tucker; Tsegaye Bekele; Katherine Gibson; Saara Greene; Colleen Price; J J Jay Koornstra; Laverne Monette; Steve Byers; James Watson; Stephen W Hwang; Dale Guenter; James Dunn; Amrita Ahluwalia; Michael G Wilson; Jean Bacon
Journal:  Open Med       Date:  2011-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.